Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

Long-Term Primary Care Saves Lives — and Is Hard to Achieve

New research quantifies the benefits of long-term patient relationships. How can you build them in a system that prioritizes high-volume access?

Size Matters for Chest Tubes

New data show similar outcomes with large-bore and small-bore chest tubes in patients with pneumothoraces.

UnitedHealthcare to Drop Prior Authorization Requirements for Range Of Conditions From Oct. 1

UnitedHealth's insurance unit said on Tuesday that a broad range of conditions will no ⁠longer need prior approval, effective October 1, as it aims to eliminate prior...

Rilzabrutinib May Be Promising in IgG4-Related Disease

Rilzabrutinib treatment is associated with a reduction in disease activity in patients with IgG4-related disease and enables most patients to discontinue glucocorticoids without experiencing flares.

What to Know About ‘Musculoskeletal Syndrome of Menopause’

Is new joint pain in perimenopause simple arthralgia or underlying inflammatory arthritis? Learn key diagnostic steps, seronegative RA risks, and hormone replacement therapy insights.

Strategies to Optimize Sepsis Outcomes

Multi-society position paper presents strategies for improvement at the hospital and systems level.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Latest News

New research quantifies the benefits of long-term patient relationships. How can you build them in a system that prioritizes high-volume access?

New data show similar outcomes with large-bore and small-bore chest tubes in patients with pneumothoraces.

UnitedHealth's insurance unit said on Tuesday that a broad range of conditions will no ⁠longer need prior approval, effective October 1, as it aims to eliminate prior...

Rilzabrutinib treatment is associated with a reduction in disease activity in patients with IgG4-related disease and enables most patients to discontinue glucocorticoids without experiencing flares.

Is new joint pain in perimenopause simple arthralgia or underlying inflammatory arthritis? Learn key diagnostic steps, seronegative RA risks, and hormone replacement therapy insights.

Multi-society position paper presents strategies for improvement at the hospital and systems level.

News All Time

GCA Patients Often Need Long-Term Glucocorticoids

Despite rapid diagnosis and guideline-based tapering, a substantial proportion of patients with giant cell arteritis remain dependent on glucocorticoid therapy for years.

Artificial Intelligence Boosts Automated Biolabs

AI and machine learning are kicking synthetic biology up to new levels of innovation. Researchers see huge potential for novel drugs and other chemicals; some also see risks.

Hospital Medicine: Good Onboarding of Hospitalists Pays Off

In years past, new hospitalists got a brief orientation and went to work. A more comprehensive approach — onboarding — is now the norm. It pays off in ways other than the bottom line.

Can Conversational AI Platforms Free Up Physicians’ Time?

Conversational agents are taking on scheduling, intake, and follow-ups, whereas clinics assess whether automation can ease administrative demands on physicians.

Branded Bevacizumab: Retina Breakthrough or Bankbuster?

Bevacizumab is a cornerstone retina drug that has been used off-label for decades. Where the FDA-cleared branded version fits in may be a matter of cost and acceptance.

Worker Violence, Staff Shortages Spark Hospital Strikes

Healthcare workers are facing more violence and staff shortages, fueling hospital strikes as workers push for safer workplaces and enough staff to care for patients.

Retinal Thinning Predicts Cognitive Decline in MS

Thinning of specific retinal layers predicts cognitive worsening in patients with multiple sclerosis, even without disease relapses — suggesting the eye may reveal hidden neurodegeneration.

Intensive Nurse-Led Supportive Care Tied to Better QOL

Higher nurse-led supportive care intensity is associated with a better quality of life and lower symptom burden in patients receiving palliative chemotherapy, a study reports.

Best Treatments for BD: Current Evidence, New Online Tool

A ‘living’ evidence review of bipolar disorder treatments has been transformed into a free, continuously updated online tool that helps clinicians and patients weigh efficacy, side effects, and individual preferences.

Add-On Citicoline May Improve Motor Function in PD

Citicoline added to dopaminergic therapy is safe and tied to higher odds of clinically meaningful improvement than placebo in motor function in Parkinson’s, a trial shows.

How Two Brains Can Quickly Be ‘On the Same Wavelength’

Researchers are learning which situations encourage neural synchrony — that increasingly elusive feeling of being ‘in flow’ with others — and how we can benefit.

Up the Ante for Lung Cancer Screening in Women

Rising incidence calls for more recognition of lung cancer risks in nonsmoking women.

As Federal Loan Cap Takes Effect, Medical Schools Step Up

Medical schools are reaching out to inform students and make more funds available after federal help shrinks. Students debate best options.

Brain Age Tied to Dementia Risk in Those With Memory Issues

An automated MRI measure shows that each extra year the brain appears older than chronologic age is linked to increased dementia risk, especially in patients with subjective cognitive concerns.

Talk Therapy for Mental Health Not So Effective in ADHD

Adults with ADHD show improvement after psychological therapy for depression and anxiety, but they are less likely than those without ADHD to achieve reliable improvement or recovery.